Localisation of malignant glioma by a radiolabelled human monoclonal antibody.

AUTOR(ES)

Phillips, J

RESUMO

Human monoclonal antibodies were produced by fusing intratumoral lymphocytes from patients with malignant gliomas with a human myeloma line. One antibody was selected for further study after screening for binding activity to glioma cell lines. The patient from whom it was derived developed recurrent glioma. 1 mg of antibody was purified, radiolabelled with 131I, and administered intravenously. The distribution of antibody was determined in the blood, CSF and tumour cyst fluid and compared with that of a control human monoclonal immunoglobulin. Antibody localisation in the tumour was observed and confirmed by external scintiscanning.

Documentos Relacionados

• Selective blockade of human natural killer cells by a monoclonal antibody.
• Studies of a human T lymphocyte antigen recognized by a monoclonal antibody.
• Separation of functional subsets of human T cells by a monoclonal antibody.
• Detection of rotavirus in human stools by using monoclonal antibody.
• Cell surface antigens of human melanoma identified by monoclonal antibody.